Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention

BACKGROUND: The CYP2C19 nonfunctional genotype reduces clopidogrel effectiveness after percutaneous coronary intervention (PCI). Following clinical implementation of CYP2C19 genotyping at University Florida (UF) Health Shands Hospital in 2012, where genotype results are available approximately 3 day...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transl Med
Autors principals: Cavallari, Larisa H., Franchi, Francesco, Rollini, Fabiana, Been, Latonya, Rivas, Andrea, Agarwal, Malhar, Smith, D. Max, Newsom, Kimberly, Gong, Yan, Elsey, Amanda R., Starostik, Petr, Johnson, Julie A., Angiolillo, Dominick J.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5896099/
https://ncbi.nlm.nih.gov/pubmed/29642909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1469-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars